BioRegenx, Inc.
BRGX
$0.0115
-$0.0005-4.17%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.55% | -4,559.56% | 88.89% | -12.73% | -1,128.09% |
| Total Depreciation and Amortization | -97.84% | 0.00% | -33.98% | 73.87% | 41,608.33% |
| Total Amortization of Deferred Charges | -89.51% | 66.28% | -65.32% | 121.43% | -- |
| Total Other Non-Cash Items | -99.48% | 6,879.58% | -111.83% | -3.91% | 769.93% |
| Change in Net Operating Assets | 42.77% | 239.66% | -70.28% | -43.57% | 196.72% |
| Cash from Operations | 430.70% | 63.46% | 90.21% | -205.47% | 57.53% |
| Capital Expenditure | -- | -- | -100.00% | 310.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | 0.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 683,259.26% | 98.65% |
| Cash from Investing | -- | -- | -100.00% | 9,987.62% | 4.41% |
| Total Debt Issued | -- | -97.36% | 127.64% | -168.50% | 11,438.46% |
| Total Debt Repaid | -22.35% | 17.48% | -116.61% | 456.32% | -6.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.72% | -114.87% | 100.25% | -6,676.26% | -44.96% |
| Foreign Exchange rate Adjustments | -152.50% | 253.85% | -620.00% | -50.00% | 211.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 315.38% | -192.13% | 122.36% | -407.14% | -116.62% |